303
Participants
Start Date
October 31, 2016
Primary Completion Date
October 31, 2017
Study Completion Date
August 31, 2018
Placebo
Bimekizumab
Bimekizumab in different dosages.
As0008 001, Duncansville
As0008 005, Aventura
As0008 030, Sarasota
As0008 019, Anniston
As0008 006, Dallas
As0008 018, Houston
As0008 020, Austin
As0008 009, Upland
As0008 007, La Jolla
As0008 014, Portland
As0008 002, Seattle
As0008 022, Ormond Beach
As0008 027, Boston
As0008 021, Freehold
As0008 015, Cleveland
As0008 156, Dobrich
As0008 151, Plovdiv
As0008 154, Plovdiv
As0008 155, Plovdiv
As0008 150, Rousse
As0008 101, Québec
As0008 100, Victoria
As0008 103, Winnipeg
As0008 205, Brno
As0008 206, Hustopeče
As0008 207, Olomouc
As0008 208, Pardubice
As0008 201, Prague
As0008 202, Prague
As0008 209, Prague
As0008 210, Prague
As0008 211, Prague
As0008 203, Zlín
As0008 302, Cologne
As0008 304, Hamburg
As0008 308, Hanover
As0008 303, Herne
As0008 301, Ratingen
As0008 400, Budapest
As0008 403, Budapest
As0008 402, Debrecen
As0008 401, Veszprém
As0008 466, Bydgoszcz
As0008 453, Elblag
As0008 456, Elblag
As0008 455, Krakow
As0008 461, Lublin
As0008 467, Nowa Sól
As0008 451, Poznan
As0008 462, Poznan
As0008 450, Torun
As0008 454, Warsaw
As0008 459, Warsaw
As0008 457, Wroclaw
As0008 460, Wroclaw
As0008 465, Wroclaw
As0008 601, Moscow
As0008 604, Moscow
As0008 605, Moscow
As0008 607, Moscow
As0008 600, Saint Petersburg
As0008 606, Saint Petersburg
As0008 608, Saint Petersburg
As0008 609, Saint Petersburg
As0008 610, Saint Petersburg
As0008 801, A Coruña
As0008 800, Córdoba
As0008 803, Santiago de Compostela
As0008 700, Kiev
As0008 707, Kyiv
As0008 705, Ternopil
As0008 708, Uzhhorod
As0008 706, Vinnytsia
As0008 704, Zaporizhya
UCB Biopharma S.P.R.L.
INDUSTRY